Contact this trialFirst, we need to learn more about you.
PI3K Inhibitor
Alpelisib for Melanoma
Recruiting1 awardPhase 2
Tucson, Arizona
This trial studies the effectiveness of alpelisib in treating HPV-associated head and neck cancer. Alpelisib works by blocking enzymes needed for cell growth, which may stop the growth of tumor cells.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.